pH News and Research

RSS

pH comes from the term “power of Hydrogen”, or the hydrogen ion concentration present in a given solution. It helps to measure the acidity or alkalinity of a substance.

Moderate chocolate consumption lowers heart failure risk: Study

Middle-aged and elderly Swedish women who regularly ate a small amount of chocolate had lower risks of heart failure risks, in a study reported in Circulation: Heart Failure, a journal of the American Heart Association.

18 Aug 2010

Research confirms genetic link to advanced fatty liver disease

Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation. Both studies are available in the September issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

17 Aug 2010

Sport Endurance develops new formula that enables safe consumption of Creatine

Sport Endurance, Inc, a health supplement company, has developed a revolutionary formula that enables the safe consumption of Creatine, a proven muscle-building and performance enhancing dietary supplement.

17 Aug 2010

International cultivator wins Canada's prestigious medical marijuana quality award

An internationally-respected hydroponics medical marijuana cultivation educator won Canada's most prestigious medical marijuana quality award during a Toronto hydroponics expo competition...and he used a brand new type of hydroponics nutrients to do it.

12 Aug 2010

Helmsley Charitable Trust awards $3.15M grant to support UofL James Graham Brown Cancer Center

The University of Louisville has received a $3.15 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to support the UofL James Graham Brown Cancer Center and cancer research taking place in Owensboro. The grant will be matched with state "Bucks for Brains" funding to bring more than $4.5 million to the Owensboro Cancer Research Program.

6 Aug 2010

ARIAD reports $159.3 million second-quarter net income

ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010 and provided an update on corporate developments.

5 Aug 2010

Team to execute research strategies surrounding oil spill health outcomes

While oil from the Deepwater Horizon spill may have stopped gushing into the Gulf of Mexico, experts are far from finished working to anticipate, outline and minimize the disaster's potential health risks, says a University of Alabama at Birmingham School of Public Health researcher actively involved in helping the federal government deal with repercussions from the April 20 accident.

31 Jul 2010

AACP, FDA and HRSA partner to introduce study that positively impacts patient health

The American Association of Colleges of Pharmacy, in partnership with the U.S. Food and Drug Administration and the Office of Pharmacy Affairs in the Health Resources and Services Administration, has completed a baseline evaluation of the integration of the "Science of Safety" into the curriculum of the Doctor of Pharmacy degree at accredited colleges and schools of pharmacy.

27 Jul 2010

Adult circumcision proposed for possible HIV prevention in gay men

Adult circumcision has been proposed as a possible HIV prevention strategy for gay men, but a new study by the University of Pittsburgh Graduate School of Public Health presented at the XVIII International AIDS Conference suggests it would have a very small effect on reducing HIV incidence in the United States.

22 Jul 2010

Study shows potential impact of syringe type on injection-related HIV epidemics among drug users

Syringe type affects HIV transmission among intravenous drug users, according to a study by researchers at RTI International. The study, published online in Addiction, used a mathematical model to illustrate the potential impact of syringe type on injection-related HIV epidemics in low- and high-risk intravenous drug user populations.

22 Jul 2010

Benefits of drug L-methionine for neurogenic bladder disorders unclear

It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010.

20 Jul 2010

Report identifies gaps in research for 20 suspected carcinogens

A new report from the American Cancer Society and other world-leading health groups identifies gaps in research for 20 suspected carcinogens whose potential to cause cancer is as yet unresolved. The report is designed to prioritize agents for additional research, and to lead to well-planned epidemiologic or mechanistic studies leading to more definitive classification of these agents.

16 Jul 2010

New REMESENSE TOOTH DESENSITIZER for treating tooth hypersensitivity

Nuline Pharmaceuticals, LLC announces the introduction of REMESENSE (dipotassium oxalate 3%) TOOTH DESENSITIZER, an Rx Class II medical device now available in the U.S. REMESENSE was introduced globally in 2008. It is presently sold in 16 countries, ranging from England and the European Union to Asia and Africa. Nuline expects to launch REMESENSE in Canada and other countries later this year or by early 2011.

15 Jul 2010

Study evaluates physicians' experiences related to colleagues who are impaired to practice medicine

A survey of physicians finds that while most support the professional commitment to report other physicians who they feel are incompetent or impaired, such as from alcohol or drug use, when faced with this situation, many did not follow through on making a report, according to a study in the July 14 issue of JAMA.

14 Jul 2010

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, today announced a study showing how the TheraDoc clinical surveillance system helped clinicians at Memorial Hospital Miramar reduce catheter-related infections, which correlated with an increase in infection-control interventions.

14 Jul 2010

Manila Bulletin reports on WHO's efforts to address migration of global health workers

The Manila Bulletin reports on how the WHO is working with countries that have high rates of migrating health workers to maintain and expand the health workforce in areas with the greatest need, expecially low-income rural communities.

13 Jul 2010

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.

9 Jul 2010

Barriers to dental care among Californian children

Lack of dental care continues to be a significant problem for American children, who miss about 1.6 million school days each year due to dental disease.

8 Jul 2010

Asian Development Bank, U.N. call on Asia-Pacific countries to increase agriculture funding to ensure food security

Countries in Asia and the Pacific should increase investment in agriculture by $120 billion annually through 2050 to address hunger and prevent major food price increases, U.N. and Asian Development Bank (ADB) officials said Wednesday, the Associated Press reports. According to the officials, the "onus for funding the investments would be on private sources and governments," the news service writes (7/7).

8 Jul 2010

Three Rivers Pharmaceuticals receives FDA expanded labeling for INFERGEN

Three Rivers Pharmaceuticals, LLC, today received expanded labeling from the U.S. Food and Drug Administration (FDA) to include daily use of INFERGEN (Consensus Interferon) in combination with ribavirin (RBV) for retreatment of chronic hepatitis C patients. The expanded labeling targets hepatitis C patients who need retreatment.

6 Jul 2010